Recommendations of the Spanish Group on Crohn¿s Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients Rocío Ferreiro-Iglesias; Marta Piqueras; Elena Ricart; Laura Sempere; Mariona Roca; Javier Martín de Carpi; Olga Benítez; Yamile Zabana; Míriam Mañosa; Francisco Rodríguez-Moranta; Manuel Barreiro-de Acosta;

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies Xavier Calvet; Daniel Carpio; Iago Rodríguez-Lago; Rosario García-Vicuña; Manuel Barreiro-de-Acosta; Xavier Juanola; Mariam Aguas; Concepción Castillo; Jordi Gratacós;

A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study) Diego Casas Deza; Ana Belén Julián Gomara; Eva Caudevilla Biota; Belén Beltrán; Eugeni Domènech; Ana Gutiérrez Casbas; Miriam Mañosa; Yamile Zabana; Lourdes Roc Alfaro; Emilio Valverde Romero; Elena García González; Beatriz Sicilia; Viviana Laredo; Maria José Alcalá Escriche; Lucia Madero Velázquez; Rocío Ferreiro-Iglesias; Antonia Palmero Pérez; Margalida Calafat; Saioa Rubio Iturria; Irene Moraleja Yudego; Yolanda Ber Nieto; Sandra García Mateo; Javier P. Gisbert; Raquel Vicente Lidón; Lara Arias; Erika Alfambra; Ana Belén Doñate Borao; Elena Peña González; Pilar Corsino Roche; Miren Vicuña Arregui; Ainara Elorza; Manuel Domínguez Cajal; María Chaparro; Manuel Barreiro-de Acosta; Santiago García-López;